Poland Some of the top stories emanating from Poland’s pharma industry, including Polish biotech Ryvu Therapeutics’ exclusive deal with Exelixis, the partnership between Polpharma and startup Pikralida on a promising epilepsy candidate and Adamed’s expansion of its laboratory facilities. Exelixis and Ryvu Therapeutics Sign Agreement to Develop Novel STING Agonist-Based…
See our Cookie Privacy Policy Here